CBE ID
3688
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Fall 2027
1.3 Measure Description
Standardized infection ratio (SIR) based on fully electronic capture of healthcare facility-onset, antibiotic-Treated Clostridioides difficile Infection (HT-CDI) events among inpatients in the facility
-
-
1.5 Measure Type
-
1.14 Numerator
Total number of observed incident healthcare facility-onset, antibiotic-treated CDI (HTCDI) events among all inpatients in the facility.
-
1.15 Denominator
Total number of expected incident HT-CDI events based on predictive models using facility-level and patient-level factors.
-
OLD 1.12 MAT output not attachedAttached1.13a Data dictionary not attachedNo
-
Most Recent Endorsement ActivityEndorsed Patient Safety Fall 2022Initial EndorsementLast Updated
-
StewardCenters for Disease Control and PreventionSteward Organization POC EmailMeasure Developer Secondary Point Of Contact
United States
-
-
-
Risk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Fall 2022 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Fall 2022 “Intent to Submit.” Battelle took over the E&M work for the Fall 2022 cycle after developers and/or stewards submitted their full measure information to NQF, which for CBE #3688, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2024-02/3688.zip
Battelle took over the E&M work beginning with the public comment period to close the E&M committees for the post-comment meeting, convening the CSAC to render a final endorsement decision, and executing the appeals period.